دورية أكاديمية

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’

التفاصيل البيبلوغرافية
العنوان: Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’
المؤلفون: Mele, G.Aff1, IDs00277022048570_cor1, Cascavilla, N., Di Renzo, N., Guarini, A., Mazza, P., Melillo, L., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Germano, C., Mele, A., Palazzo, G., Palumbo, G., Reddiconto, G., Rossini, B., Specchia, G., Musto, P., Pastore, D.
المصدر: Annals of Hematology. 101(8):1727-1739
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:09395555
14320584
DOI:10.1007/s00277-022-04857-0